Volume 17, Number 4—April 2011
Nosocomial Pandemic (H1N1) 2009, United Kingdom, 2009–2010
|Patient no.||Age, y/sex||Duration, d
||Maximum level of care*||Outcome†|
|Hospital admission to symptom onset||Symptom onset to receipt of antiviral therapy|
|4||18/F||4||Not given||2||Transferred to other hospital|
|11||44/F||14||Not given||3||Transferred, improved|
*Level 0 care is given to patients whose care needs can be met through normal ward care. Level 1 care is given to patients at risk for a deteriorating condition or recently relocated from higher levels of care whose needs can be met in an acute-care ward with additional advice and support from the critical-care team. Level 3 care is given to patients requiring advanced respiratory support alone or basic respiratory support and support for >2 organ systems; this level includes all patients with complex conditions that required support for multiorgan failure (intensive care unit). Level 2 care is given to patients requiring more detailed observation or intervention, including support for a single failing organ system and those changing from higher levels of care (high dependency unit).
†Deaths were attributed to pandemic (H1N1) 2009.
‡Oseltamivir was replaced with zanamivir on day 5 because of identification of the H275Y drug-resistance mutation.
- Page created: July 25, 2011
- Page last updated: July 25, 2011
- Page last reviewed: July 25, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)